Resultados de la búsqueda 121-130 of 17854 for B cell lymphomas
... B-cell lymphoma 2 (BCL2) inhibitor. A Study of CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma. Jacksonville, Fla ...
... B-cell Lymphoma. Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville ... B-cell lymphoma with respect to PFS as assessed by the investigator.
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
The purpose of this study is to evaluate the safety and tolerability of STP938 as a single agent in adult subjects with R/R B-cell and T-cell lymphomas. A Study ...
Mayo Clinic doctors and researchers are studying T-cell lymphomas to look for new ways to improve diagnosis and treatment for this cancer. Cancer research is ...
... b-cell lymphoma (DLBCL) patients with out of ... cell lymphoma that has come back or does not respond to treatment. ... A virus, called VSV-hIFNbeta-NIS, which has ...
Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. ... B-cell lymphoma 2 (BCL2) ...
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?